Characterization and application of roxithromycin loaded cyclodextrin based nanoparticles for treatment of multidrug resistant bacteria
Tài liệu tham khảo
Black, 2010, Global, regional, and national causes of child mortality in 2008: a systematic analysis, Lancet, 375, 1969, 10.1016/S0140-6736(10)60549-1
Asea, 2010, Enteroaggregative Escherichia coli: an emerging enteric food borne pathogen, Interdiscip. Perspect. Infect. Dis., 2010
Mellata, 2013, Human and avian extraintestinal pathogenic Escherichia coli: infections, zoonotic risks, and antibiotic resistance trends, Foodborne Pathog. Dis., 10, 916, 10.1089/fpd.2013.1533
Dulon, 2011, MRSA prevalence in European healthcare settings: a review, BMC Infect. Dis., 11, 138, 10.1186/1471-2334-11-138
Biradar, 2006, A comparative study of approaches used to improve solubility of roxithromycin, Powder Technol., 169, 22, 10.1016/j.powtec.2006.07.016
Siedenbiedel, 2012, Antimicrobial polymers in solution and on surfaces: overview and functional principles, Polymers (Basel), 4, 46, 10.3390/polym4010046
Muñoz-Bonilla, 2015, The roadmap of antimicrobial polymeric materials in macromolecular nanotechnology, Eur. Polym. J., 65, 46, 10.1016/j.eurpolymj.2015.01.030
Muñoz-Bonilla, 2012, Polymeric materials with antimicrobial activity, Prog. Polym. Sci., 37, 281, 10.1016/j.progpolymsci.2011.08.005
Ma, 2012, The comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailability, Int. J. Nanomedicine, 7, 559
Yallapu, 2010, Beta-cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells, Colloids Surf. B Biointerfaces, 79, 113, 10.1016/j.colsurfb.2010.03.039
Danciu, 2014, Genistein in 1:1 inclusion complexes with ramified cyclodextrins: theoretical, physicochemical and biological evaluation, Int. J. Mol. Sci., 15, 1962, 10.3390/ijms15021962
Perret, 2013, Design, synthesis, and in vitro evaluation of new amphiphilic cyclodextrin-based nanoparticles for the incorporation and controlled release of acyclovir, Eur. J. Pharm. Biopharm., 83, 25, 10.1016/j.ejpb.2012.09.013
Michel, 2012, Design and evaluation of cyclodextrin-based delivery systems to incorporate poorly soluble curcumin analogs for the treatment of melanoma, Eur. J. Pharm. Biopharm., 81, 548, 10.1016/j.ejpb.2012.03.016
Fernandes, 2002, Physicochemical characterization and in vitro dissolution behavior of nicardipine–cyclodextrins inclusion compounds, Eur. J. Pharm. Sci., 15, 79, 10.1016/S0928-0987(01)00208-1
Abdelghany, 2012, Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection, Int. J. Nanomedicine, 7, 4053
Du, 2009, Preparation and characteristics of hydroxypropyl-β-cyclodextrin polymeric nanocapsules loading nimodipine, Eur. Polym. J., 45, 1397, 10.1016/j.eurpolymj.2009.01.031
Jeong, 2008, Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity, Int. J. Pharm., 352, 317, 10.1016/j.ijpharm.2007.11.001
He, 2007, Improved bioavailability of orally administered mifepristone from PLGA nanoparticles, Int. J. Pharm., 334, 173, 10.1016/j.ijpharm.2006.10.025
Mura, 2010, Development of a new delivery system consisting in ‘drug-in cyclodextrin-in PLGA nanoparticles’, J. Microencapsul., 27, 479, 10.3109/02652040903515508
Song, 2011, Cyclodextrin–erythromycin complexes as a drug delivery device for orthopedic application, Int. J. Nanomedicine, 6, 3173
Wongmekiat, 2007, Preparation of drug nanoparticles by co-grinding with cyclodextrin: formation mechanism and factors affecting nanoparticle formation, Chem. Pharm. Bull. (Tokyo), 55, 359, 10.1248/cpb.55.359
Nanthakasri, 2011, Biodegradable blend nanoparticles of amphiphilic diblock copolymers prepared by nano-precipitation method, 2011, 561
Bell, 1968, Preparation of agar wells for antibiotic assay, Appl. Microbiol., 16, 1611, 10.1128/AEM.16.10.1611-1612.1968
SAS Institute Inc., 2004, vol. 1
Perret, 2013, Preparation and characterization of CK2 inhibitor-loaded cyclodextrin nanoparticles for drug delivery, Int. J. Pharm., 441, 491, 10.1016/j.ijpharm.2012.11.004
Khalil, 2012, Preparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal delivery, Carbohydr. Polym., 90, 1244, 10.1016/j.carbpol.2012.06.056
Hirlekar, 2009, Preformulation study of the inclusion complex irbesartan–beta-cyclodextrin, AAPS PharmSciTech, 10, 276, 10.1208/s12249-009-9206-5
Loftsson, 2011, Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes, J. Pharm. Pharmacol., 63, 1119, 10.1111/j.2042-7158.2011.01279.x
Zhang, 2013, Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective, Adv. Drug Deliv. Rev., 65, 1215, 10.1016/j.addr.2013.05.001
Davis, 2004, Cyclodextrin-based pharmaceutics: past, present and future, Nat. Rev. Drug Discov., 3, 1023, 10.1038/nrd1576
Uekama, 1998, Cyclodextrin drug carrier systems, Chem. Rev., 98, 2045, 10.1021/cr970025p
Masood, 2013, Encapsulation of ellipticine in poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) based nanoparticles and its in vitro application, Mater. Sci. Eng. C Mater. Biol. Appl., 33, 1054, 10.1016/j.msec.2012.11.025
Bilensoy, 2008, Development of nonsurfactant cyclodextrin nanoparticles loaded with anticancer drug paclitaxel, J. Pharm. Sci., 97, 1519, 10.1002/jps.21111
Ringard-Lefebvre, 2002, Effect of spread amphiphilic β-cyclodextrins on interfacial properties of the oil/water system, Colloids Surf. B Biointerfaces, 25, 109, 10.1016/S0927-7765(01)00297-1
Szejtli, 1982
Mittal, 2007, Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo, J. Control. Release, 119, 77, 10.1016/j.jconrel.2007.01.016
Koopaei, 2012, Enhanced antibacterial activity of roxithromycin loaded pegylated poly lactide-co-glycolide nanoparticles, Daru, 20, 92, 10.1186/2008-2231-20-92
Aleem, 2008, Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir, J. Pharm. Biomed. Anal., 47, 535, 10.1016/j.jpba.2008.02.006